Calyon Securitieis Initiates Coverage Diversified Electronics Stocks
More News related to APH
- ALDA Enters into Agreement with Shoppers Drug Mart
- ALDA Enters into Agreement with Shoppers Drug Mart
- ALDA Products Now Available at Marketplace IGA
- ALDA Products Now Available at Marketplace IGA
- Munck Carter Obtains Complete Defense Verdict in Eastern District of Texas Patent Infringement Case
More News related to MOLX
- Molex Receives Prestigious Ford Motor Company Q1 Award
- Molex Receives "Outstanding Performance Supplier" Award from Sanmina-SCI
- Molex Expands RF Capabilities with Zhenjiang Tean Telecom & Appliance Co., Ltd. Acquisition
- Molex Announces iPass+(TM) HSC CXP Copper and Optical System for Fast and Flexible System Hardware
- Molex Offers Safety Program to Electrical Safety Industry for Hands-on Training and Awareness for Common Electrical Safety Hazards
More News related to SYNA
- Synaptics to Present at Upcoming Investor Conferences
- Synaptics Announces Put Option for 0.75% Convertible Senior Subordinated Notes Due 2024
- Synaptics to Present at Lazard Capital Markets Technology & Media Best Ideas Investor Day
- After-Hours Movers 10/22: AMZN, SYNA, ALGN, RNOW, COF, PWER Higher; HOKU, SPWRA, BRCM, BJRI, SNV, IBKR Lower
- Synaptics (SYNA) Reports Q EPS of $0.48-adj.; Guides
More News related to New Coverage
- Regency Energy (RGNC) Announces 10M Unit Public Offering
- SWS Group (SWS) Commences 4.1M Share Equity Offering
- GeoResources (GEOI) Closes 3.45M Share Offering for Proceeds of $33M
- U.S. Energy (USEG) to Offer 5M Shares of Common Stock
- Acuity Brands (AYI) Announces $400M Senior Unsecured Note Private Offering
Calyon Securities initiates coverage on Amphenol (NYSE: APH) with an Outperform - Price target $37.
Calyon initiates coverage on Molex (Nasdaq: MOLX) with an Underperform - Price target $17.
Calyon initiates coverage on Synaptics (Nasdaq: SYNA) with a Buy - Price target $37.50.
Related Categories
New CoverageStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
